Gadolinium‐based contrast agent exposures and physical and cognitive disability in multiple sclerosis

BACKGROUND AND PURPOSE: The clinical correlation of gadolinium‐based contrast agents (GBCAs) has not been well studied in multiple sclerosis (MS). We investigated the extent to which the number of GBCA administrations relates to self‐reported disability and performance measures. METHODS: A cohort of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kunio, McGinley, Marisa P., Jones, Stephen E., Lowe, Mark J., Cohen, Jeffrey A., Ruggieri, Paul M., Ontaneda, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847209/
https://www.ncbi.nlm.nih.gov/pubmed/36181666
http://dx.doi.org/10.1111/jon.13057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847209/
https://www.ncbi.nlm.nih.gov/pubmed/36181666
http://dx.doi.org/10.1111/jon.13057

Ejemplares similares